The prophylactic reduction of aluminium intake.
The use of modern analytical methods has demonstrated that aluminium salts can be absorbed from the gut and concentrated in various human tissues, including bone, the parathyroids and brain. The neurotoxicity of aluminium has been extensively characterized in rabbits and cats, and high concentrations of aluminium have been detected in the brain tissue of patients with Alzheimer's disease. Various reports have suggested that high aluminium intakes may be harmful to some patients with bone disease or renal impairment. Fatal aluminium-induced neuropathies have been reported in patients on renal dialysis. Since there are no demonstrable consequences of aluminium deprivation, the prophylactic reduction of aluminium intake by many patients would appear prudent. In this report, the major sources of aluminium in foods and non-prescription drugs are summarized and alternative products are described. The most common foods that contain substantial amounts of aluminium-containing additives include some processed cheeses, baking powders, cake mixes, frozen doughs, pancake mixes, self-raising flours and pickled vegetables. The aluminium-containing non-prescription drugs include some antacids, buffered aspirins, antidiarrhoeal products, douches and haemorrhoidal medications. The advisability of recommending a low aluminium diet for geriatric patients is discussed in detail.
D000535:Aluminum / Q000008:administration & dosage* / Q000032:analysis / Q000633:toxicity; D000818:Animals; D003297:Cooking and Eating Utensils; D005503:Food Additives / Q000032:analysis; D005504:Food Analysis; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008903:Minerals / Q000378:metabolism; D009420:Nervous System / Q000187:drug effects; D010280:Parathyroid Glands / Q000378:metabolism
D005503:Food Additives; D008903:Minerals; D000535:Aluminum